Amit Gupta Sells 6,498 Shares of Cardlytics (NASDAQ:CDLX) Stock

Cardlytics, Inc. (NASDAQ:CDLX) CEO Amit Gupta sold 6,498 shares of the business’s stock in a transaction on Thursday, July 2nd. The shares were sold at an average price of $4.39, for a total transaction of $28,526.22. Following the completion of the sale, the chief executive officer directly owned 123,490 shares in the company, valued at $542,121.10. This represents a 5.00% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink.

Amit Gupta also recently made the following trade(s):

• On Monday, July 6th, Amit Gupta sold 9,640 shares of Cardlytics stock. The shares were sold at an average price of $4.39, for a total value of $42,319.60.

Cardlytics Trading Down 2.5%

Shares of CDLX opened at $4.26 on Wednesday. The stock has a market capitalization of $24.75 million, a price-to-earnings ratio of -0.24 and a beta of 0.61. Cardlytics, Inc. has a 12 month low of $4.06 and a 12 month high of $32.80. The firm has a fifty day simple moving average of $6.16 and a 200 day simple moving average of $8.67.

Wall Street Analysts Forecast Growth

Several brokerages have issued reports on CDLX. Lake Street Capital set a $10.00 price target on Cardlytics in a report on Friday, May 8th. Needham & Company LLC reissued a “hold” rating on shares of Cardlytics in a research report on Thursday, June 18th. Wall Street Zen cut shares of Cardlytics from a “hold” rating to a “sell” rating in a research note on Saturday, June 13th. Finally, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Cardlytics in a report on Friday, April 10th. Two analysts have rated the stock with a Hold rating and two have given a Sell rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Reduce” and a consensus target price of $10.00.

Institutional Inflows and Outflows

Hedge funds have recently added to or reduced their stakes in the company. Goldman Sachs Group Inc. grew its position in Cardlytics by 15.1% in the fourth quarter. Goldman Sachs Group Inc. now owns 109,001 shares of the company’s stock valued at $125,000 after acquiring an additional 14,273 shares during the last quarter. Geode Capital Management LLC boosted its stake in shares of Cardlytics by 3.3% in the 4th quarter. Geode Capital Management LLC now owns 654,472 shares of the company’s stock valued at $753,000 after purchasing an additional 20,908 shares in the last quarter. Qube Research & Technologies Ltd acquired a new stake in shares of Cardlytics in the 3rd quarter valued at approximately $55,000. Boothbay Fund Management LLC bought a new stake in shares of Cardlytics during the 3rd quarter valued at approximately $74,000. Finally, Virtu Financial LLC bought a new stake in shares of Cardlytics during the 4th quarter valued at approximately $39,000. 68.10% of the stock is owned by institutional investors.

About Cardlytics

Cardlytics, Inc operates a purchase intelligence and marketing platform that connects advertisers with consumers through bank and credit card transaction data. The company partners with financial institutions to analyze anonymized purchase information, enabling brands to deliver highly targeted offers and rewards directly to customers’ online and mobile banking channels. By leveraging real-time insights into consumer spending habits, Cardlytics helps marketers optimize campaign performance and measure return on ad spend more accurately than traditional digital advertising methods.

At the core of Cardlytics’ offering is its proprietary purchase intelligence engine, which aggregates and anonymizes transaction data from partner banks and credit unions.